Ibrance
- Product NDC
- 0069-0187
- 11-digit product format
- 000690187
- Labeler code
- 0069
- Product ID
- 0069-0187_fb858b80-8bd4-43a6-8871-9819a35ca03f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- palbociclib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA207103
- Marketing category
- NDA
- Marketing start
- 2015-02-03
- Marketing end
- 2029-03-31
- Substance
- PALBOCICLIB
- Active strength
- 75 mg/1
- Pharmacologic classes
- Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ibrance
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PALBOCICLIB | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G9ZF61LE7G |
| Rxcui | 1601380, 1601386, 1601388, 1601390, 1601392, 1601394 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0069-0187-21 | Ibrance | 21 in 1 BOTTLE | CAPSULE | 21 | | 21 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0069-0187 | IBRANCE (PALBOCICLIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 18 | Current NDC, Legacy NDC, 1 package rows | 20250507_e0e6412f-50b4-4fd4-9364-62818d121a07.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0069-0187-21 | 00069018721 | 21 CAPSULE in 1 BOTTLE (0069-0187-21) | 21 capsule | 2015-02-03 | 0000-00-00 | No | No | Current |